Click on headlines below to download research

Driving innovation in a thriving CGT industry
Oxford Biomedica | 27/05/2021

Oxford Biomedica (OXB) is one of few global lentiviral vector manufacturers with capacity in a thriving cell and gene therapy industry, and its FY20 results…

Executive interview
Oxford Biomedica – executive interview | 24/02/2021

Why are investors buying into Oxford Biomedica (LN:OXB)? In this interview, BBC broadcaster Vivienne Parry OBE asks CEO John Dawson why Oxford Biomedica…